Novobiocin

Novobiocin is a coumarin-derived antibiotic obtained from Streptomyces niveus. Among its listed roles, it functions as a antibacterial agent, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor, an antimicrobial agent, an Escherichia coli metabolite and a hepatoprotective agent. It is a hexoside, a monocarboxylic acid amide, a monosaccharide derivative, a hydroxycoumarin, an ether, a carbamate ester and a member of phenols. It is the conjugate acid of novobiocin(1-). It is grouped under the following drug class(es): PARP Inhibitors. The directory classifies it as a discontinued API with a fermentation-derived source/manufacturing origin. Other names for this substance include Streptonivicin, Cardelmycin and Inamycin. Its PubChem CID is 54675769.

CAS No 303-81-1
Molecular Formula C31H36N2O11
Molecular Weight 612.6 g/mol
Synonyms [(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate

Frequently Asked Questions